Immunohistochemical Analysis of Human Mesenchymal Stem Cells Differentiating into Chondrogenic, Osteogenic, and Adipogenic Lineages

Methods in Molecular Biology

Volumn 698, Issue , 2011, Pages 353-366

  Yang, Zheng ^b   Schmitt, Jacqueline Frida ^b   Lee, Eng Hin ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NONE

Author keywords

Chondrogenic; Differentiation; Immunohistochemical analysis; Mesenchymal stem cells; Osteogenic and adipogenic

Indexed keywords

BONE MARROW; CELL MEMBRANE POTENTIAL; CELL POPULATION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; MUSCLE; REGENERATION; SYNOVIUM; ADIPOGENESIS; ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL SEPARATION; CHONDROGENESIS; CULTURE TECHNIQUE; CYTOLOGY; METABOLISM; METHODOLOGY; PROTEIN SYNTHESIS; STAINING;

ALCIAN BLUE; ALIZARIN; ANTHRAQUINONE DERIVATIVE; AZO COMPOUND; COLLAGEN; MINERAL; OIL RED O; PHENAZINE DERIVATIVE; PROTEOGLYCAN; SAFRANIN T;

ADIPOGENESIS; ALCIAN BLUE; ANIMALS; ANTHRAQUINONES; AZO COMPOUNDS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CHONDROGENESIS; COLLAGEN; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; MINERALS; OSTEOGENESIS; PHENAZINES; PROTEIN BIOSYNTHESIS; PROTEOGLYCANS; STAINING AND LABELING;

EID: 79959804038     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-999-4_26     Document Type: Chapter

References (18)

1. Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A.I., Goldberg V.M. (1994) Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76, 579–92.
2. Lee K.B., Hui J.H., Song I.C., Ardany L., Lee E.H. (2007) Injectable mesenchymal stem cell therapy for large cartilage defects–a porcine model. Stem Cells 25, 2964–71.
3. Chong A.K., Ang A.D., Goh J.C., Hui J.H., Lim A.Y., Lee E.H., Lim B.H. (2007) Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit achilles tendon model. J Bone Joint Surg Am 89, 74–81.
4. Lee E.H., Hui J.H. (2006) The potential of stem cells in orthopaedic surgery. J Bone Joint Surg Br 88, 841–51.
5. Koc O.N., Gerson S.L, Cooper B.W., Dyhouse S.M., Haynesworth S.E., Caplan A.I., Lazarus H.M. (2000) Rapid hematopoietic recovery after co-infusion of autologous blood stem cells and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high dose chemotherapy. J Clin Oncol 8, 307–16.
6. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99, 8932–7.
7. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98, 10344–49.
8. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., Entman M.L., Michael L.H., Hirschi K.K., Goodell M.A. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107, 1395–402.
9. Chamberlain G., Fox J., Ashton B., Middleton J. (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25, 2739–49. Review
10. Caplan A.I. (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217, 318–24. Review.
11. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., Gerson S.L. (1998) Phenotypic and functional comparison of cultures of marrow derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176, 57–66.
12. Haynesworth S.E., Baber M.A., Caplan A.I. (1996) Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1a. J Cell Physiol 166, 585–92.
13. Aggarwal S., Pittenger M.F. (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815–22.
14. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838–43.
15. González M.A., Gonzalez-Rey E., Rico L., Büscher D., Delgado M. (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60, 1006–19.
16. Oh J.Y., Kim M.K., Shin M.S., Lee H.J., Ko J.H., Wee W.R., Lee J.H. (2008) The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 26, 1047–55.
17. Yoo J.U., Barthel T.S., Nishimura K., Solchaga L., Caplan A.I., Goldberg V.M., Johnstone B. (1998) The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80, 1745–57.
18. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. (1998) In vitro chondrogensis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238, 265–72.